Tempest Therapeutics TPST
NASDAQ TPST
$1.05 +0.03 (+3.43%)
As of: Aug 21, 2026 · 10:09 AM EDT

Tempest Therapeutics (TPST) Gross Margin (QoQ) (2015 - 2018)

Tempest Therapeutics (TPST) Gross Margin (QoQ) (2015 - 2018) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 140.52 Bn 132.67 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.54 Bn 78.55 Bn 3.93 Bn
3 Argenx Se 65.31 Bn 60.13 Bn 1.37 Bn
4 Moderna 61.77 Bn 56.64 Bn 52.00 Mn
5 BeOne Medicines 42.26 Bn 37.16 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.19 Bn 27.88 Bn 992.69 Mn
7 BioNTech SE 28.71 Bn 10.31 Bn 668.28 Mn
8 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
9 Royalty Pharma 27.35 Bn 26.52 Bn -
10 Tempest Therapeutics 4.38 Mn 3.58 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2018 -1,333.00
Jun 30, 2018 10,050.00
Mar 31, 2018 7,240.00
Dec 31, 2017 -18,777.00
Sep 30, 2017 27,440.00
Jun 30, 2017 10,079.00
Mar 31, 2017 75,731.00
Dec 31, 2016 -39,293.00
Sep 30, 2016 -13,899.00
Jun 30, 2016 15,310.00
Mar 31, 2016 -6,790.00
Dec 31, 2015 51,575.00
Sep 30, 2015 -86,667.00
Jun 30, 2015 -15,333.00